The rate of Entecavir resistance in Naïve and Lamivudine-resistance chronic hepatitis B patients during 3 years of treatment

Colonno RJ. AASLD 2006. Abstract 110.<p><b>Copyright information:</b></p><p>Taken from "The role of entecavir in the treatment of chronic hepatitis B"</p><p></p><p>Therapeutics and Clinical Risk Management 2007;3(6):1077-1086.</p><p>Published online Jan 2007</p><p>PMCID:PMC2387288.</p><p>© 2007 Dove Medical Press Limited. All rights reserved</p

Comparison of responses to treatment (HBeAg seroconversion and log reduction of serum HBV DNA) of HBeAg positive chronic hepatitis B

. , 352:2682–95. Dienstag et al. 1999. , 341:1256–63. . , Abstract 73. Lai et al. 2005. , Abstract 72404.(LB1) Chang et al. 2004 , Abstract 70. Telbivudine package insert. . . 348:808–16. Chang et al. 2006. . 354:1001–10.<p><b>Copyright information:</b></p><p>Taken from "The role of entecavir in the treatment of chronic hepatitis B"</p><p></p><p>Therapeutics and Clinical Risk Management 2007;3(6):1077-1086.</p><p>Published online Jan 2007</p><p>PMCID:PMC2387288.</p><p>© 2007 Dove Medical Press Limited. All rights reserved</p